COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Zixin Pharmaceutical on obtaining a pharmaceutical production license through the new GMP certification and whol

Page view
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-001
Jilin Zixin Pharmaceutical Co., Ltd.
About the adoption of the new version of GMP certification and wholly-owned
Announcement of Subsidiary Obtaining Pharmaceutical Production License


The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

1. the company passed the new version of GMP certification

In accordance with the State Food and Drug Administration's "Administrative Measures for the Administration of Pharmaceutical Production Quality Management Standards" and the "Notice on Implementing the "Good Manufacturing Practices for Pharmaceutical Production (Revised in 2010)" (Guo Food and Drug Administration [2011] No. 101) It is stipulated that Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “Company”) meets the requirements of the “Good Manufacturing Practices (2010 Revision)” and has been awarded Jilin by the Jilin Provincial Food and Drug Administration. The new version of the "Drug GMP Certificate" issued by the Provincial Food and Drug Administration (Certificate No.: JL20120021), the company's preparation workshop and Chinese medicine pre-treatment and extraction workshop passed the national new version of GMP certification. The certification details are as follows:

Certification scope: hard capsules, tablets, pills (honey pills, water honey pills, water pills, concentrated pills, paste pills), granules, oral solution, mixture, lozenge, oral solution

Certificate validity: until January 3, 2018


2. The wholly-owned subsidiary obtained the Pharmaceutical Production License.

On January 4, 2013, the company's wholly-owned subsidiary Jilin Zixin Prajna Pharmaceutical Co., Ltd. (hereinafter referred to as: Prajna Pharmaceutical) obtained the Pharmaceutical Production License issued by Jilin Food and Drug Administration, certificate number: Ji 2012041 Valid until: December 31, 2015, production address and production range: Xidian Street, Lanshi Economic Development Zone, Jilin Province, Pills (Honey Pills, Shuimi Pills, Water Pills, Concentrated Pills). Prasal Pharmaceuticals can produce and sell drugs after obtaining the GMP certification for pharmaceutical products.


Special announcement 

Jilin Zixin Pharmaceutical Co., Ltd.
Board of Directors
January 7, 2013